Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enanta Pharmaceuticals (ENTA) Q2 2026 Earnings
ENTA
11
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.02
-0.82
-0.62
-0.42
Details
Expected EPS
-0.487337
Actual EPS
-0.45
Surprise EPS
0.04
Surprise Percent
+7.66%
Description
Enanta Pharmaceuticals (ENTA) has reported earnings of -0.45 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login